Increased expression and aberrant localization of mucin 13 in metastatic colon cancer

Journal of Histochemistry and Cytochemistry

Volumn 60, Issue 11, 2012, Pages 822-831

  Gupta, Brij K ^a,b   Maher, Diane M ^a   Ebeling, Mara C ^a   Sundram, Vasudha ^a   Koch, Michael D ^b,c   Lynch, Douglas W ^b,c   Bohlmeyer, Teresa ^a   Watanabe, Akira ^d   Aburatani, Hiroyuki ^d   Puumala, Susan E ^a   Jaggi, Meena ^b   Chauhan, Subhash C ^b  

^a SANFORD RESEARCH   (United States)

^b UNIVERSITY OF SOUTH DAKOTA   (United States)

^c UNIVERSITY OF SOUTH DAKOTA   (United States)

^d UNIVERSITY OF TOKYO   (Japan)

Author keywords

Colon cancer metastasis; Immunohistochemistry; MUC13; Mucin

Indexed keywords

MONOCLONAL ANTIBODY; MONOCLONAL ANTIBODY MUC13; MUCIN; MUCIN 13; UNCLASSIFIED DRUG; MUC13 PROTEIN, HUMAN; RNA;

ADULT; ARTICLE; CANCER CELL CULTURE; CANCER TISSUE; CELLULAR DISTRIBUTION; CLINICAL ARTICLE; COHORT ANALYSIS; COLON CANCER; COLON METASTASIS; CONTROLLED STUDY; CYTOPLASM; FEMALE; GENE EXPRESSION PROFILING; GENE OVEREXPRESSION; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; LIVER METASTASIS; MALE; METASTATIC COLON CANCER; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN LOCALIZATION; TISSUE MICROARRAY; TUMOR DIFFERENTIATION; CELL NUCLEUS; COLON; COLON TUMOR; GENE EXPRESSION REGULATION; GENETICS; LIVER; LIVER TUMOR; METABOLISM; METASTASIS; PATHOLOGY; TUMOR CELL LINE; UPREGULATION;

CELL LINE, TUMOR; CELL NUCLEUS; COHORT STUDIES; COLON; COLONIC NEOPLASMS; CYTOPLASM; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; IMMUNOHISTOCHEMISTRY; LIVER; LIVER NEOPLASMS; MUCINS; RNA; TISSUE ARRAY ANALYSIS; UP-REGULATION;

EID: 84872016791     PISSN: 00221554     EISSN: None     Source Type: Journal    
DOI: 10.1369/0022155412460678     Document Type: Article

References (17)

1. Chauhan SC, Ebeling MC, Maher DM, Koch MD, Watanabe A, Aburatani H, Lio Y, Jaggi M. 2012. MUC13 mucin augments pancreatic tumorigenesis. Mol Cancer Ther. 1:24-33.
2. Chauhan SC, Vannatta K, Ebeling MC, Vinayek N, Watanabe A, Pandey KK, Bell MC, Koch MD, Aburatani H, Lio Y, et al. 2009. Expression and functions of transmembrane mucin MUC13 in ovarian cancer. Cancer Res. 69:765-774.
3. Cone RA. 2009. Barrier properties of mucus. Adv Drug Deliv Rev. 61:75-85.
4. Fearon ER, Vogelstein B. 1990. A genetic model for colorectal tumorigenesis. Cell. 61:759-767.
5. Gao J, McConnell MJ, Yu B, Li J, Balko JM, Black EP, Johnson JO, Lloyd MC, Altiok S, Haura EB. 2009. MUC1 is a downstream target of STAT3 and regulates lung cancer cell survival and invasion. Int J Oncol. 35:337-345.
6. Jemal A, Center MM, DeSantis C, Ward EM. 2010. Global patterns of cancer incidence and mortality rates and trends. Cancer Epidemiol Biomarkers Prev. 19:1893-1907.
7. Leibovitz A, Stinson JC, McCombs WB III, McCoy CE, Mazur KC, Mabry ND. 1976. Classification of human colorectal adenocarcinoma cell lines. Cancer Res. 36:4562-4569.
8. Maher DM, Gupta BK, Nagata S, Jaggi M, Chauhan SC. 2011. Mucin 13: structure, function, and potential roles in cancer pathogenesis. Mol Cancer Res. 9:531-537.
9. McAuley JL, Linden SK, Png CW, King RM, Pennington HL, Gendler SJ, Florin TH, Hill GR, Korolik V, McGuckin MA. 2007. MUC1 cell surface mucin is a critical element of the mucosal barrier to infection. J Clin Invest. 117:2313-2324.
10. Packer LM, Williams SJ, Callaghan S, Gotley DC, McGuckin MA. 2004. Expression of the cell surface mucin gene family in adenocarcinomas. Int J Oncol. 25:1119-1126.
11. Sheng YH, Lourie R, Lindén SK, Jeffery PL, Roche D, Tran TV, Png CW, Waterhouse N, Sutton P, Florin TH, et al. 2011. The MUC13 cell-surface mucin protects against intestinal inflammation by inhibiting epithelial cell apoptosis. Gut. 60(12):1661-1670.
12. Shimamura T, Ito H, Shibahara J, Watanabe A, Hippo Y, Taniguchi H, Chen Y, Kashima T, Ohtomo T, Tanioka F, et al. 2005. Overexpression of MUC13 is associated with intestinal-type gastric cancer. Cancer Sci. 96:265-273.
13. Siegel R, Ward E, Brawley O, Jemal A. 2011. Cancer statistics, 2011: the impact of eliminating socioeconomic and racial disparities on premature cancer deaths. CA Cancer J Clin. 61:212-236.
14. Singh AP, Moniaux N, Chauhan SC, Meza JL, Batra SK. 2004. Inhibition of MUC4 expression suppresses pancreatic tumor cell growth and metastasis. Cancer Res. 64:622-630.
15. Walsh MD, Young JP, Leggett BA, Williams SH, Jass JR, McGuckin MA. 2007. The MUC13 cell surface mucin is highly expressed by human colorectal carcinomas. Hum Pathol. 38:883-892.
16. Williams SJ, Wreschner DH, Tran M, Eyre HJ, Sutherland GR, McGuckin MA. 2001. Muc13, a novel human cell surface mucin expressed by epithelial and hemopoietic cells. J Biol Chem. 276:18327-18336.
17. Workman HC, Miller JK, Ingalla EQ, Kaur RP, Yamamoto DI, Beckett LA, Young LJ, Cardiff RD, Borowsky AD, Carraway KL, et al. 2009. The membrane mucin MUC4 is elevated in breast tumor lymph node metastases relative to matched primary tumors and confers aggressive properties to breast cancer cells. Breast Cancer Res. 11:R70.